This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
The reason appeal keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
Picking up post #31: that is the part I would want checked first.
Appeal is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes before adding to this one.
I had written a reply contradicting post #31 and deleted it. Here is what survived.
Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or are contraindicated are often exactly what an appeals process needs.
The right answer here may simply be that it has not been measured.
What I would want before treating appeal as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing.
Worth separating two things that post #31 runs together.
Agreed on appeal, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and the starting assumption is the part nobody states.
This follows post #35 rather than contradicting it.
A peer-to-peer review is available in many systems and is frequently more productive than a written appeal, because it is a conversation with somebody who can decide.
The short answer was in the first line; everything after is the working.
Grateful for the specificity. Vague answers to this question are what sent me looking.
Post #35 and I disagree about the size of the effect, not about the direction.
Appeal deadlines are strict and are stated in the letter. Missing one is the most avoidable way to lose.
Written in the hope of being told what I have missed.
Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and responding point-by-point to it works better than general appeals.
The variance between people here is larger than the effect being discussed.
Narrowing post #40, because the general version has more than one answer.
Keep every document with dates in one place. An appeal months later is assembled from whatever you kept.
That is what I would do. It may not be what is correct.
Where I have landed on appeal, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed it from somewhere that did not measure it.
Post #43 and I disagree about the size of the effect, not about the direction.
Worth separating appeal as a question about the compound from appeal as a question about the documentation. They get answered by different people and only one of them is answerable here.
Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.
I would call that likely rather than established.
Building on post #44 rather than restating it.
I would put moderate confidence on the mainstream reading of appeal and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
Post #46 put the caveat in the right place and I want to underline it.
On appeal: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here including this one.
Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy.
Post #46 describes the usual case. This is about the unusual one.
Before the thread moves on from appeal — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and from an n of four hundred.
Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer.
Not the answer, but possibly the question that gets there.
Adding the measurement that post #49 says would settle it.
The denial letter is the specification for your appeal. It states a criterion, and the job is to demonstrate that the criterion is met in the letter's own language.
Adding a source would improve this post and I do not have one to hand.
Trying to state the appeal position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.
Following this. I have the same question and no better information than the first post.
Answering the question post #53 raises rather than the one it answers.
Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or are contraindicated are often exactly what an appeals process needs.
The arithmetic in post #53 is right; the assumption feeding it is the part to check.
I would keep appeal and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why the last one went badly.
Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy.
That is a description of practice, not a recommendation of it.
Small methodological point on appeal: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Two questions I would want answered before drawing anything from the appeal data above: how were the cases selected, and what happened to the ones that dropped out.
Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.
Written from notes rather than memory, which is why the numbers are specific.